Literature DB >> 17474783

Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker.

Xiaohua Huang1, Ivan H El-Sayed, Wei Qian, Mostafa A El-Sayed.   

Abstract

Human oral cancer cells are found to assemble and align gold nanorods conjugated to anti-epidermal growth factor receptor (anti-EGFR) antibodies. Immnoconjugated gold nanorods and nanospheres were shown previously to exhibit strong Rayleigh (Mie) scattering useful for imaging. In the present letter, molecules near the nanorods on the cancer cells are found to give a Raman spectrum that is greatly enhanced (due to the high surface plasmon field of the nanorod assembly in which their extended surface plasmon fields overlap), sharp (due to a homogeneous environment), and polarized (due to anisotropic alignments). These observed properties can be used as diagnostic signatures for cancer cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17474783     DOI: 10.1021/nl070472c

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  75 in total

1.  Raman chemical imaging of chromate reduction sites in a single bacterium using intracellularly grown gold nanoislands.

Authors:  Sandeep P Ravindranath; Kristene L Henne; Dorothea K Thompson; Joseph Irudayaraj
Journal:  ACS Nano       Date:  2011-06-07       Impact factor: 15.881

Review 2.  Molecular imaging with SERS-active nanoparticles.

Authors:  Yin Zhang; Hao Hong; Duane V Myklejord; Weibo Cai
Journal:  Small       Date:  2011-09-20       Impact factor: 13.281

3.  Hyperspectral molecular imaging of multiple receptors using immunolabeled plasmonic nanoparticles.

Authors:  Kevin Seekell; Matthew J Crow; Stella Marinakos; Julie Ostrander; Ashutosh Chilkoti; Adam Wax
Journal:  J Biomed Opt       Date:  2011-11       Impact factor: 3.170

4.  Multilayered polyelectrolyte-coated gold nanorods as multifunctional optical contrast agents for cancer cell imaging.

Authors:  Li-li Chen; Li Jiang; Ya-lun Wang; Jun Qian; Sailing He
Journal:  J Zhejiang Univ Sci B       Date:  2010-06       Impact factor: 3.066

5.  Imaging of epidermal growth factor receptor on single breast cancer cells using surface-enhanced Raman spectroscopy.

Authors:  Lifu Xiao; Sitaram Harihar; Danny R Welch; Anhong Zhou
Journal:  Anal Chim Acta       Date:  2014-06-21       Impact factor: 6.558

Review 6.  Hybrid nanoparticles for detection and treatment of cancer.

Authors:  Michael J Sailor; Ji-Ho Park
Journal:  Adv Mater       Date:  2012-05-21       Impact factor: 30.849

7.  Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level.

Authors:  Iris E Allijn; Wei Leong; Jun Tang; Anita Gianella; Aneta J Mieszawska; Francois Fay; Ge Ma; Stewart Russell; Catherine B Callo; Ronald E Gordon; Emine Korkmaz; Jan Andries Post; Yiming Zhao; Hans C Gerritsen; Axel Thran; Roland Proksa; Heiner Daerr; Gert Storm; Valentin Fuster; Edward A Fisher; Zahi A Fayad; Willem J M Mulder; David P Cormode
Journal:  ACS Nano       Date:  2013-10-17       Impact factor: 15.881

Review 8.  Aptamer-conjugated nanomaterials and their applications.

Authors:  Liu Yang; Xiaobing Zhang; Mao Ye; Jianhui Jiang; Ronghua Yang; Ting Fu; Yan Chen; Kemin Wang; Chen Liu; Weihong Tan
Journal:  Adv Drug Deliv Rev       Date:  2011-10-14       Impact factor: 15.470

9.  Off-resonance surface-enhanced Raman spectroscopy from gold nanorod suspensions as a function of aspect ratio: not what we thought.

Authors:  Sean T Sivapalan; Brent M Devetter; Timothy K Yang; Thomas van Dijk; Matthew V Schulmerich; P Scott Carney; Rohit Bhargava; Catherine J Murphy
Journal:  ACS Nano       Date:  2013-03-05       Impact factor: 15.881

10.  Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres.

Authors:  Wei Lu; Chiyi Xiong; Guodong Zhang; Qian Huang; Rui Zhang; Jin Z Zhang; Chun Li
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.